Medera’s SPAC Merger Marks Rare Biotech Move
Medera aims for Nasdaq listing via SPAC to boost gene therapies, spotlighting rare biotech SPACs in 2024.
- Latest
- Trending
Medera aims for Nasdaq listing via SPAC to boost gene therapies, spotlighting rare biotech SPACs in 2024.
Boehringer Ingelheim acquires Saiba Animal Health, boosting pet R&D with innovative therapeutic vaccines.
SparkLabs announces $50M AIM AI Fund to support AI startups, expanding opportunities beyond Silicon Valley.
NHG integrates AI for lung, heart screening, enhancing radiology workflow efficiency and patient care.
Revolutionary solvent-based method removes 98% of nanoplastics from water, promising cleaner oceans and safer ecosystems.
Learn how investing £500 monthly can lead to a lifetime second income of £56,400 by smartly diversifying your portfolio.
Biotech firms restructure with layoffs as FDA approves new drugs, exemplifying industry challenges and opportunities.
Cassava Sciences stands out as a leading debt-free stock with significant upside potential, offering strong financial health.
Federal push to harness AI in medical research relies on extensive data collection and privacy safeguards.
Sinovac's 2024 revenue drops amidst market challenges, with ongoing vaccine development and international market expansions.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.